Butyramide and monobutyrin: growth inhibitory and ...[Anticancer Res. 1993 Jan-Feb]

SearchDatabase nameforSearch term

Advanced Search

Your browser version may not work well with NCBI's Web applications. More information here...

Display Show

All: 1

Review: 0

Click to change filter selection through MyNCBI.

1: Anticancer Res. 1993 Jan-Feb;13(1):145-9.Links

Butyramide and monobutyrin: growth inhibitory and differentiating agents.

Lea MA, Xiao Q, Sadhukhan A, Sharma S, Newmark HL.

Department of Biochemistry and Molecular Biology, UMDNJ-New Jersey Medical School, Newark 07103.

Butyramide and monobutyrin were chosen for study as neutral compounds that might exhibit some of the growth inhibitory and differentiating effects of butyrate. Inhibitory effects on DNA synthesis in hepatoma cells and on cellular proliferation in mouse erythroleukemia cells were observed. Induction of differentiation by butyramide and monobutyrin was seen in mouse erythroleukemia cells as monitored by increased synthesis of hemoglobin and H1 zero histone. Butyramide and monobutyrin were less effective inducers of hemoglobin synthesis than butyrate but their neutral character may offer an advantage in the induction of tumor cell differentiation.

PMID: 8476205 [PubMed - indexed for MEDLINE]

Alteration in proportions of histone H1 variants during the differentiation of murine erythroleukaemic cells. [Biochem J. 1992]
Discordant effects of butyrate analogues on erythroleukemia cell proliferation, differentiation and histone deacetylase. [Anticancer Res. 1995]
Inhibitory effects of tea extracts and (-)-epigallocatechin gallate on DNA synthesis and proliferation of hepatoma and erythroleukemia cells. [Cancer Lett. 1993]
ReviewReprogramming erythroleuekmia cells to terminal differentiation and terminal cell division. [Front Biosci. 2000]
ReviewInstability and stabilization in melanoma cell differentiation. [Curr Top Dev Biol. 1986]

Display Show

Butyramide and monobutyrin: growth inhibitory and differentiating agents.

Related Articles